Bacchus Vascular was founded by Dr. Thomas J. Fogarty in 1999 as an innovative medical device company dedicated to help physicians battle limb and life threatening blood clots in their patients. Currently, Bacchus has two product platforms, the Fino System and the Trellis System. Both products are CE Marked with the Trellis System receiving 510(k) clearance this year, as a peripheral infusion catheter for selective infusion of physician specified agents including thrombolytics. To date, over 300 patients have been treated worldwide with these Bacchus blood clot management systems.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 02/12/08 | Series E | 15M | Buckhead Investment Partners, BLH Venture Partners, Kaplan Ventures, Super Angels, Board | Unknown |
People
Eric Heil (VP Sales)
Kelvin Ning (Director of Product Marketing)
Anthony Sowunmi (Director of Quality Assurance & Regulatory Affairs)
Scott Cramer (President/CEO)
David Jansen (Director of Market Development)
News
Bacchus Vascular gets $15M for clot-busting device
February 11, 2008 5:40 pm
See our story on this Santa Clara, Calif., medical-device maker in today’s daily briefing at VentureBeat Life Sciences. Continue reading ⟩
Life sciences briefing: Monday, Feb. 11, 2008
February 11, 2008 4:43 pm
TODAY’S HEADLINES: PolyRemedy, developer of robotic wound care, takes in $25M (release) Bacchus Vascular gets $15M for clot-busting device (VentureWire)… Continue reading ⟩
Life sciences briefing: Wednesday, Oct. 17, 2007
October 17, 2007 2:56 pm
Featured companies: Algorithme Pharma, Bacchus Vascular, Botaneco, Cubist Pharmaceuticals, Ikonisys, Healthcare Management Systems, Illumigen Biosciences, Kilmer Capital Partners, Medical Specialties… Continue reading ⟩